A Combined Oral Regimen of EGCG and Silibinin Inhibited the Subcutaneous Growth of the CT-26 Colon Cancer Cell Line and Had NO Adverse Effect on Abdominal or Gastric Wound Healing
- Resource Type
- Journal
- Source
GASTROENTEROLOGY ; MAY 2010, 138 5, pS906-pS906, 1p. Supplement: 1- Subject
- Language
- English
- ISSN
- 15280012